Journal profile · ONCOLOGY
Progress in Tumor Research
ISSN 0079-6263 · Karger · SWITZERLAND · Semiannual · Founded 1960
FollowGet an email when its zone, impact factor or warning status changes
Progress in Tumor Research: subscription journal; community-reported acceptance: easy; 0 articles in 2025.
Scope
Aims, scope and focus
Progress in Tumor Research is published by Karger. By OpenAlex counts of its recent articles, its largest topics are Science, Research, and Medicine, Cancer Cells and Metastasis and Cancer-related Molecular Pathways, together about 29.4% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The scientific book series 'Progress in Tumor Research' aims to provide in depth information about important developments in cancer research. The individual volumes are authored and edited by experts to provide detailed coverage of topics selected as either representing controversial issues or belonging to areas where the speed of developments necessitates the kind of assistance offered by integrative, critical reviews.
Source: LetPub
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Science, Research, and MedicineMedicine11.8%
- Cancer Cells and MetastasisMedicine8.8%
- Cancer-related Molecular PathwaysMedicine8.8%
- Global Cancer Incidence and ScreeningMedicine5.9%
- Cancer, Stress, Anesthesia, and Immune ResponseMedicine5.9%
- Glioma Diagnosis and TreatmentMedicine2.9%
- Cervical Cancer and HPV ResearchMedicine2.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cancer Research | Q4 | 156/198 | 21st |
| Oncology | Q3 | 214/331 | 35th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 2.5LetPub ·
- SJR 2026-06
- 0.25LetPub ·
- SNIP 2026-06
- 0.41LetPub ·
- h-index
- 6LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 20 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 3 |
| 2025 | 0 | 0 | 3 |
| 2024 | 0 | 0 | 3 |
| 2023 | 0 | 0 | 6 |
| 2022 | 0 | 0 | 5 |
| 2021 | 0 | 0 | 3 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Before you submit
Three checks before submitting to Progress in Tumor Research
- 1ScopeRecent output centres on Science, Research, and Medicine, Cancer Cells and Metastasis.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Karger
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Semiannual
- Founded
- 1960
- ISSN
- 0079-6263
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Progress in Tumor Research
Is Progress in Tumor Research open access, and what is the APC?
Progress in Tumor Research is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .